X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (256) 256
Publication (30) 30
Book Chapter (23) 23
Report (10) 10
Book / eBook (4) 4
Patent (4) 4
Book Review (3) 3
Dissertation (3) 3
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (140) 140
male (108) 108
oncology (70) 70
middle aged (64) 64
female (62) 62
aged (60) 60
index medicus (60) 60
adult (45) 45
chemotherapy (43) 43
cancer (42) 42
treatment outcome (35) 35
canada (33) 33
aged, 80 and over (30) 30
drug therapy (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
urology & nephrology (25) 25
clinical trials as topic (23) 23
antineoplastic agents - therapeutic use (22) 22
care and treatment (22) 22
clinical trials (21) 21
cisplatin (20) 20
randomized controlled trials as topic (20) 20
research (19) 19
disease-free survival (18) 18
survival analysis (18) 18
therapy (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
medicine & public health (17) 17
metastasis (17) 17
prognosis (17) 17
prostate cancer (17) 17
antineoplastic agents - adverse effects (15) 15
carcinoma (15) 15
neoplasm staging (15) 15
prostatic neoplasms - therapy (15) 15
radiotherapy (15) 15
carcinoma, transitional cell - drug therapy (14) 14
cisplatin - administration & dosage (14) 14
quality of life (14) 14
survival (14) 14
trial (14) 14
urinary bladder neoplasms - drug therapy (14) 14
diagnosis (13) 13
pharmacology & pharmacy (13) 13
retrospective studies (13) 13
combined modality therapy (12) 12
dosage and administration (12) 12
head and neck neoplasms - drug therapy (12) 12
prostatic neoplasms - drug therapy (12) 12
cancer therapies (11) 11
docetaxel (11) 11
follow-up studies (11) 11
neoplasm metastasis (11) 11
parent participation (11) 11
patient outcomes (11) 11
pharmacology/toxicology (11) 11
squamous cell carcinoma (11) 11
academic achievement (10) 10
analysis (10) 10
carcinoma, squamous cell - drug therapy (10) 10
disease progression (10) 10
kidney neoplasms - drug therapy (10) 10
patients (10) 10
surgery (10) 10
antimitotic agents (9) 9
antineoplastic agents (9) 9
drug administration schedule (9) 9
health aspects (9) 9
medical research (9) 9
original research (9) 9
phase-iii trial (9) 9
prostatic neoplasms (9) 9
randomized-trial (9) 9
squamous-cell carcinoma (9) 9
time factors (9) 9
urologic neoplasms - therapy (9) 9
abridged index medicus (8) 8
carcinoma, squamous cell - mortality (8) 8
carcinoma, transitional cell - pathology (8) 8
elementary secondary education (8) 8
gemcitabine (8) 8
head and neck cancer (8) 8
head and neck neoplasms - mortality (8) 8
head and neck neoplasms - pathology (8) 8
hematology, oncology and palliative medicine (8) 8
medicine, experimental (8) 8
parent school relationship (8) 8
proportional hazards models (8) 8
risk factors (8) 8
survival rate (8) 8
urinary bladder neoplasms - pathology (8) 8
urinary bladder neoplasms - therapy (8) 8
vinblastine (8) 8
abiraterone acetate (7) 7
comparative analysis (7) 7
complications and side effects (7) 7
cooperative-oncology-group (7) 7
deoxycytidine - administration & dosage (7) 7
deoxycytidine - analogs & derivatives (7) 7
expression (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Urology, ISSN 0022-5347, 08/2018, Volume 200, Issue 2, pp. 351 - 352
Journal Article
The Journal of Urology, ISSN 0022-5347, 08/2018, Volume 200, Issue 2, pp. 351 - 352
Journal Article
Journal of Urology, ISSN 0022-5347, 08/2018, Volume 200, Issue 2, pp. 351 - 352
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 138 - 148
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2019, Volume 20, Issue 10, pp. 1349 - 1359
Transoral robotic surgery (TORS) with concurrent neck dissection has supplanted radiotherapy in the USA as the most common treatment for oropharyngeal squamous... 
Journal Article
JAMA, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 09/2017, Volume 99, Issue 1, pp. 8 - 8
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 697 - 710
Summary Background Previous trials have shown that anti-EGFR monoclonal antibodies can improve clinical outcomes of patients with recurrent or metastatic... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | P16 | ONCOLOGY | COLORECTAL-CANCER | OROPHARYNGEAL CANCER | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | III TRIAL | COOPERATIVE-ONCOLOGY-GROUP | PLUS FLUOROURACIL | Immunohistochemistry | South America | Head and Neck Neoplasms - virology | Prospective Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Neoplasm Recurrence, Local - virology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | North America | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Head and Neck Neoplasms - chemistry | Neoplasm Metastasis | Carcinoma, Squamous Cell - mortality | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Fluorouracil - administration & dosage | Time Factors | Female | Retrospective Studies | Biomarkers, Tumor - analysis | Europe | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Papillomaviridae - isolation & purification | Neoplasm Recurrence, Local - chemistry | Head and Neck Neoplasms - pathology | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Biopsy | Carcinoma, Squamous Cell - secondary | Aged | Head and Neck Neoplasms - mortality | Care and treatment | Relapse | Carcinoma | Monoclonal antibodies | Product development | Metastasis | Cisplatin | Cancer | Diseases | Index Medicus
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 769 - 776
Summary Background No standard treatment exists for patients with platinum-refractory urothelial cancer. Taxanes and vinflunine are commonly used, but response... 
Hematology, Oncology and Palliative Medicine | SPARC | CISPLATIN | ONCOLOGY | NAB-PACLITAXEL | TRANSITIONAL-CELL CARCINOMA | RANDOMIZED-TRIAL | OPEN-LABEL | II TRIAL | CANCER | DOCETAXEL | GEMCITABINE | Albumins - chemistry | Albumin-Bound Paclitaxel | Humans | Middle Aged | Ureteral Neoplasms - pathology | Male | Drug Carriers - chemistry | Urothelium - pathology | Nanoparticles | Ureteral Neoplasms - drug therapy | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Albumins - adverse effects | Time Factors | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - adverse effects | Carcinoma - secondary | Carcinoma - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Paclitaxel - adverse effects | Albumins - administration & dosage | Antineoplastic Agents, Phytogenic - chemistry | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Chemistry, Pharmaceutical | Canada | Disease-Free Survival | Administration, Intravenous | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Urothelium - drug effects | Antimitotic agents | Care and treatment | Albumin | Metastasis | Drug therapy | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2007, Volume 25, Issue 25, pp. 3978 - 3984
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2381 - 2391
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 10, pp. 1107 - 1113
Journal Article